High-rolling investors have positioned themselves bearish on Bausch Health Companies BHC, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in BHC often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for Bausch Health Companies. This is not a typical pattern.
The sentiment among these major traders is split, with 25% bullish and 75% bearish. Among all the options we identified, there was one put, amounting to $33,500, and 7 calls, totaling $734,262.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $9.0 to $12.0 for Bausch Health Companies over the last 3 months.
Insights into Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Bausch Health Companies options trades today is 759.25 with a total volume of 57,093.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Bausch Health Companies's big money trades within a strike price range of $9.0 to $12.0 over the last 30 days.
Bausch Health Companies Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|
BHC | CALL | TRADE | BEARISH | 03/15/24 | $9.50 | $270.0K | 63 | 12.2K |
BHC | CALL | TRADE | BULLISH | 03/15/24 | $9.50 | $229.5K | 63 | 12.4K |
BHC | CALL | SWEEP | BEARISH | 03/15/24 | $9.50 | $68.8K | 63 | 15.1K |
BHC | CALL | SWEEP | BEARISH | 03/15/24 | $9.50 | $55.1K | 63 | 316 |
BHC | CALL | SWEEP | BEARISH | 03/15/24 | $10.00 | $41.4K | 1.2K | 2.7K |
About Bausch Health Companies
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Following our analysis of the options activities associated with Bausch Health Companies, we pivot to a closer look at the company's own performance.
Present Market Standing of Bausch Health Companies
- With a trading volume of 3,517,077, the price of BHC is up by 4.96%, reaching $9.1.
- Current RSI values indicate that the stock is may be overbought.
- Next earnings report is scheduled for 0 days from now.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bausch Health Companies options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.